Expanding the Functional Food Business Using Functional Ingredients
First written in FY2016. 18 of 36 entries say "Advanced", first in FY2017. Latest entry: 2026-08-07.
0 other companies' latest entry also says "Cited as achieved".
- FY2026AdvancedAnnual report
「In beverages, the MBP Drink series of foods with function claims exceeded the previous year, and the company launched the new Snow Brand Megmilk Oishii Milk 750ml, allowing consumers to choose the volume to suit their lifestyles.」
The company continues to expand sales of MBP Drink products using functional ingredients and has introduced new products offering a choice of volumes. It has also disclosed a KPI of sales of at least ¥87 billion for priority functional products in fiscal 2030. - 2026-05-14Cited as achievedEarnings presentation
「Growing priority functional products」
For sales of priority functional products, the company presented FY2025 sales of ¥65.1 billion, a FY2026 forecast of ¥71.3 billion and a FY2030 KPI of ¥87.0 billion. - FY2026-H1AdvancedAnnual report
「In beverages, the MBP Drink series of foods with function claims exceeded the previous year. In yogurt, the Megumi megumi Gasseri SP Strain Yogurt series exceeded the previous year, helped by various promotional activities.」
The company has disclosed sales results for the MBP Drink and Gasseri SP Strain Yogurt series, supported by messaging around their functional benefits and promotional activities. - FY2025-H1AdvancedAnnual report
「Functional foods performed steadily, supported by marketing activities on marketplace e-commerce sites and other initiatives. In overseas markets, sales of functional ingredients grew significantly, but sales of powdered milk and other products declined. As a result, the Nutrition business as a whole was at the same level as the previous year.」
The company continued marketing on marketplace e-commerce sites for functional foods, while sales of functional ingredients grew significantly in overseas markets. - FY2024AdvancedAnnual report
「In beverages, the MBP Drink series of foods with function claims, the large-size Mainichi Honebuto MBP, Sukkiri Ca-Iron, Snow Brand Coffee and other products performed strongly.」
The company has continued to disclose the expansion of its product lineup and strong sales of functional products such as MBP. - FY2024-Q3AdvancedAnnual report
「Functional foods performed steadily, despite a moderation in the growth rate of the subscription-based direct-to-consumer business as the movement of people recovered following the easing of restrictions related to COVID-19, supported by active marketing activities on marketplace e-commerce sites and other initiatives.」
The company explained that functional foods performed steadily by expanding active marketing activities on marketplace e-commerce sites in addition to its subscription-based direct-to-consumer business. - FY2024-Q2RestatedAnnual report
「Functional foods exceeded the previous year, although the growth rate of the subscription-based direct-to-consumer business moderated as the movement of people recovered following the easing of restrictions related to COVID-19. In beverages, MBP Drink, a food with function claims, the large-size Mainichi Honebuto MBP, Sukkiri Ca-Iron, Snow Brand Coffee and other products performed strongly.」
The company continued its subscription-based direct-to-consumer business in functional foods, which exceeded the previous year despite a moderation in the growth rate. Foods with function claims, including MBP Drink, also continued to perform strongly. - FY2023AdvancedAnnual report
「The company established new KPIs comprising the expansion of alternative foods, such as plant-based foods, under “providing sustainable food,” and the expansion of value-added products, including products in the Nutrition business and foods with health functions, under “contributing to health through food.”」
The company continues to expand functional foods, while setting new KPIs that include sales of at least ¥100 billion in value-added products and adding alternative foods as a growth area. - FY2023-Q3RestatedAnnual report
「Functional foods continued to grow, as the subscription-based direct-to-consumer business remained strong, supported by active marketing investment and growing health consciousness.」
The company continues to expand its functional foods business through subscription-based direct-to-consumer sales and marketing investment. - FY2023-Q2RestatedAnnual report
「Functional foods continued to grow, as the subscription-based direct-to-consumer business remained strong, supported by active marketing investment and growing health consciousness. In beverages, sales of MBP Drink, the first beverage-type food with function claims in Japan to claim the function of “increasing bone density,” remained strong.」
The company continued investing in marketing for its subscription-based direct-to-consumer business, driving growth in functional foods. It also continued to report strong sales of MBP Drink. - FY2023-Q1RestatedAnnual report
「Sales of MBP Drink, the first beverage-type Foods with Function Claims product in Japan to carry the claim that it increases bone density, remained strong.」
The Company continued to disclose strong sales of MBP Drink and continued developing products using functional ingredients. - FY2022-Q3AdvancedAnnual report
「In October, the Company launched the new Lactobacillus helveticus Yogurt, a Foods with Function Claims product that alleviates eye and nose discomfort, and the improved Lactobacillus helveticus Yogurt Drink Type.」
For Foods with Function Claims products using Lactobacillus helveticus, the Company launched a new product and an improved product from October, advancing its functional-ingredient product lineup. - FY2022-Q2AdvancedAnnual report
「Net sales were ¥126,344 million, unchanged year on year, and operating income was ¥3,489 million, up 26.3%. New products such as MBP Drink, the first beverage-type Foods with Function Claims product in Japan to carry the claim that it increases bone density, contributed to higher beverage sales. In yogurt, products using Gasseri SP Strain, a lactic acid bacterium that reduces visceral fat and is being actively promoted as a food with health functions, performed well.」
Foods with Function Claims products such as MBP Drink contributed to higher sales, and the product lineup using Gasseri SP Strain also performed well. Operating income in the beverages and desserts segment increased 26.3% year on year. - FY2022-Q1AdvancedAnnual report
「New products such as MBP Drink, the first beverage-type Foods with Function Claims product in Japan to carry the claim that it increases bone density, contributed to higher beverage sales.」
The Company explained that new products using its proprietary milk-based ingredient MBP contributed to higher sales, indicating that product development using functional ingredients translated into sales performance. - FY2021AdvancedAnnual report
「On 23 March 2021, the Company launched MBP Drink 100ml. Using its proprietary milk-based ingredient MBP, the result of many years of research, it is the first Foods with Function Claims beverage in Japan to carry the claim that it increases bone density.」
In addition to its existing Gasseri SP Strain and Lactobacillus helveticus products, the Company launched a beverage-type Foods with Function Claims product using its proprietary milk-based ingredient MBP, expanding its functional-ingredient product lineup. - FY2021-Q3RestatedAnnual report
「In functional foods, the FOSHU product Mainichi Bone Care MBP grew as a result of continued marketing investment.」
The company explains that continued marketing investment in functional foods led to growth in Mainichi Bone Care MBP. - FY2021-Q2RestatedAnnual report
「In functional foods, the FOSHU product Mainichi Bone Care MBP grew as a result of continued marketing investment.」
The Company continued marketing investment in functional foods, and Every Day Bone Care MBP grew. Meanwhile, functional yogurts using Gasseri SP Strain and Lactobacillus helveticus in the beverages and desserts category declined in sales, producing mixed results by product. - FY2021-Q1RestatedAnnual report
「Yogurt products such as plain yogurt remained firm despite the effects of changing consumption trends. However, the functional yogurt products Gasseri SP Strain and Lactobacillus helveticus declined in sales despite promotional activities.」
The Company continues to communicate the functionality of Gasseri SP Strain and Lactobacillus helveticus and promote related products, but functional yogurt sales declined in the quarter. - FY2020AdvancedAnnual report
「In the yogurt category, the Company completed notification under the Foods with Function Claims system for the function of alleviating eye and nose discomfort, and launched a drinkable yogurt using its proprietary lactic acid bacterium Lactobacillus helveticus.」
In addition to Gasseri SP Strain, the Company launched Foods with Function Claims products using Lactobacillus helveticus, broadening the deployment of its functional ingredients. - FY2020-Q3RestatedAnnual report
「Yogurt sales increased slightly as the Company worked to strengthen communication of each product's value, including continued promotional activities highlighting the ability of Gasseri SP Strain to reduce visceral fat.」
The Company continues promotional activities to communicate the functionality of Gasseri SP Strain and strengthen communication of product value. - FY2020-Q2RestatedAnnual report
「Yogurt sales increased as the Company worked to strengthen communication of the value of each product, including continued promotional activities highlighting the ability of Gasseri SP Strain to reduce visceral fat.」
The Company continued promotional activities to communicate the functionality of Gasseri SP Strain and strengthen communication of product value, identifying these as factors behind higher yogurt sales. - FY2020-Q1RestatedAnnual report
「In functional foods, the FOSHU product Mainichi Bone Care MBP grew as a result of continued marketing investment.」
The company explains that continued marketing investment in functional foods led to growth in Mainichi Bone Care MBP. - FY2019AdvancedAnnual report
「In the yogurt category, the Company launched Megumi Gasseri SP Strain Yogurt, Made with Fresh Milk, a plain, unsweetened product in the Gasseri SP Strain series made only with fresh milk, dairy products, and milk protein to meet customer needs.」
The Company is expanding the product lineup used to communicate the functionality of Gasseri SP Strain, aiming to attract new users with a plain product unlike its existing offerings. - FY2019-Q3RestatedAnnual report
「Yogurt performed well as the Company strengthened promotional activities to communicate the functionality of its proprietary lactic acid bacterium, Gasseri SP Strain, including the newly launched Foods with Function Claims products Megumi Gasseri SP Strain Yogurt, Berry Mix and Megumi Gasseri SP Strain Yogurt Drink Type, Muscat.」
The Company continues to launch new Foods with Function Claims products using Gasseri SP Strain and strengthen promotional activities to communicate their functionality. - FY2019-Q2AdvancedAnnual report
「Yogurt performed well as the Company strengthened promotional activities to communicate the functionality of its proprietary lactic acid bacterium, Gasseri SP Strain, including the newly launched Foods with Function Claims products Megumi Gasseri SP Strain Yogurt Drink Type, Berry Mix and Muscat, and the relaunched Food for Specified Health Uses product Megumi Gasseri SP Strain Yogurt.」
The Company added new products using Gasseri SP Strain, advanced the renewal of existing products and strengthened promotional activities to communicate functionality, and yogurt performed well. - FY2019-Q1AdvancedAnnual report
「Yogurt performed well as the Company strengthened promotional activities to communicate the functionality of its proprietary lactic acid bacterium, Gasseri SP Strain, including the newly launched Foods with Function Claims product Megumi Gasseri SP Strain Yogurt Drink Type, Berry Mix, and the relaunched Food for Specified Health Uses product Megumi Gasseri SP Strain Yogurt.」
For Gasseri SP Strain, the Company advanced concrete product initiatives through the launch of a new product, the renewal of an existing product, and stronger promotional activities to communicate functionality. - FY2018-Q3RestatedAnnual report
「Net sales were ¥212,341 million, down 0.5% year on year, and operating income was ¥4,156 million, down 4.5%. Yogurt remained firm as the Company continued promoting the functionality of its proprietary lactic acid bacterium, Gasseri SP Strain. However, beverage sales declined because of weak market conditions, resulting in a slight decrease in sales for the segment as a whole.」
The Company explained that yogurt remained firm as it continued promoting the functionality of Gasseri SP Strain. Meanwhile, weak beverage market conditions resulted in slight declines in both sales and earnings for the segment as a whole. - FY2018-Q2AdvancedAnnual report
「Net sales were ¥143,982 million, up 0.1% year on year, and operating income was ¥3,476 million, up 6.8%. Yogurt performed well as the Company continued promoting the functionality of its proprietary lactic acid bacterium, Gasseri SP Strain. However, beverage sales declined because of weak market conditions, resulting in a slight increase in sales for the segment as a whole. Operating income increased, partly because sales of functional yogurt expanded.」
The Company continued promoting the functionality of Gasseri SP Strain and expanding sales of functional yogurt, while operating income in the beverages and desserts segment increased 6.8% year on year. - FY2018-Q1AdvancedAnnual report
「Net sales were ¥70,656 million, up 0.6% year on year, and operating income was ¥1,855 million, up 18.6%. Yogurt sales grew as the Company continued promoting the functionality of its proprietary lactic acid bacterium, Gasseri SP Strain, while beverages also performed well, resulting in higher sales for the segment as a whole. Operating income increased, partly because sales of functional yogurt expanded.」
The Company continued promoting the functionality of Gasseri SP Strain and disclosed expanded sales of functional yogurt, together with higher operating income from beverages and desserts. - FY2017AdvancedAnnual report
「In 2016, the Company also launched Megumi Gasseri SP Strain Yogurt for Home Delivery and Megumi Gasseri SP Strain Yogurt Drink Type for Home Delivery, the first home-delivery-only products to promote the function of Gasseri SP Strain in reducing visceral fat.」
The Company described a concrete commercialization achievement in extending the promotion of the Foods with Function Claims system and its proprietary lactic acid bacterium to products exclusively for home delivery. - FY2017-Q3RestatedAnnual report
「Yogurt sales increased, supported by market growth and continued efforts to promote the Company's proprietary lactic acid bacterium, Gasseri SP Strain, under the Foods with Function Claims system.」
The Company continued to use the Foods with Function Claims system and promote Gasseri SP Strain, identifying these as factors behind higher yogurt sales. - FY2017-Q2RestatedAnnual report
「Yogurt sales increased, supported by market growth and continued efforts to promote the Company's proprietary lactic acid bacterium, Gasseri SP Strain, under the Foods with Function Claims system.」
The Company continued to use the Foods with Function Claims system and promote Gasseri SP Strain, identifying these as factors behind higher sales. - FY2017-Q1RestatedAnnual report
「Yogurt sales increased, supported by market growth and continued efforts to promote the Company's proprietary lactic acid bacterium, Gasseri SP Strain, under the Foods with Function Claims system.」
The Company continued to use the Foods with Function Claims system and promote its proprietary lactic acid bacterium, identifying these as factors behind higher yogurt sales. - FY2016First statedAnnual report
「In the functional foods business, the Company will communicate the value of its proprietary functional ingredients and capture demand in the growing health foods market.」
The Company described this as an initiative to capture demand in the health foods market by communicating the value of its proprietary ingredients.